
Bridging The Commercialization Gap.
Most emerging biotechnologies never make it out of research labs into the real world. By combining deep scientific expertise with best-in-class manufacturing, ARCTERUS is able to mitigate technical risks assoiciated with emerging technologies.


Dr. Frederic Zenhausern
Whitespace Enterprises Corporation was founded in 2018 to explore emerging nano-technologies. Upon validation of our Vertical Flow Immunoassay technology, we rebranded to ARCTERUS in tribute of the brightest star in the northern celestial hemisphere.
​
The company’s founder and scientific leader, Dr. Frederic Zenhausern, has track record in discovery and product development in the field of molecular diagnostics and nanotechnology.
​
He serves as Professor and Director at the University of Arizona’s College of Medicine Phoenix Center for Applied Nanobioscience and Medicine. Dr. Zenhausern is also a Professor at the Translational Genomics Research Institute (TGen) and director of the Personalized Medicine Laboratory at Honor Health Research Institute (HHRI).
​
He has co-authored over 60 scientific publications and over twenty issued patents. Zenhausern founded several startups and currently sits on several corporate scientific boards, editorial and professional societies boards.